C15ORF29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.955100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.469400E-01
Normal-vs-Stage2
2.480000E-02
Normal-vs-Stage3
1.952200E-01
Normal-vs-Stage4
5.941800E-01
Stage1-vs-Stage2
9.047000E-01
Stage1-vs-Stage3
2.444400E-01
Stage1-vs-Stage4
7.588000E-01
Stage2-vs-Stage3
2.969800E-01
Stage2-vs-Stage4
8.178000E-01
Stage3-vs-Stage4
5.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.684300E-03
Normal-vs-AfricanAmerican
1.242240E-01
Normal-vs-Asian
4.391400E-01
Caucasian-vs-AfricanAmerican
5.882200E-01
Caucasian-vs-Asian
9.492000E-01
AfricanAmerican-vs-Asian
6.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.928210E-02
Normal-vs-Female
5.684300E-02
Male-vs-Female
7.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.925800E-01
Normal-vs-Age(41-60Yrs)
8.805800E-01
Normal-vs-Age(61-80Yrs)
2.175100E-03
Normal-vs-Age(81-100Yrs)
1.151650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.392800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.945400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.799600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.963800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.233640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.219020E-01
Normal-vs-Daily Drinker
7.453500E-02
Normal-vs-Weekly Drinker
3.240400E-01
Normal-vs-Occasional Drinker
3.866400E-01
Normal-vs-Social Drinker
4.525200E-01
Non Drinker-vs-Daily Drinker
7.436200E-01
Non Drinker-vs-Weekly Drinker
9.572000E-01
Non Drinker-vs-Occasional Drinker
3.943000E-01
Non Drinker-vs-Social Drinker
8.282200E-01
Daily Drinker-vs-Weekly Drinker
8.387600E-01
Daily Drinker-vs-Occasional Drinker
2.462600E-01
Daily Drinker-vs-Social Drinker
6.390600E-01
Weekly Drinker-vs-Occasional Drinker
5.383000E-01
Weekly Drinker-vs-Social Drinker
8.320400E-01
Occasional Drinker-vs-Social Drinker
7.148000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.806000E-02
Normal-vs-Grade 2
4.169300E-04
Normal-vs-Grade 3
6.820500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.630570E-01
Grade 1-vs-Grade 3
1.518840E-01
Grade 1-vs-Grade 4
2.806000E-02
Grade 2-vs-Grade 3
7.426600E-01
Grade 2-vs-Grade 4
4.169300E-04
Grade 3-vs-Grade 4
6.820500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.985700E-04
Normal-vs-NonDiabetic
1.504200E-01
Diabetic-vs-NonDiabetic
1.629890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.757900E-02
Normal-vs-NoPancreatitis
1.303680E-02
Pancreatitis-vs-NoPancreatitis
8.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.498800E-03
Normal-vs-N1
4.979700E-02
N0-vs-N1
3.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.296400E-01
Normal-vs-TP53-NonMutant
1.203370E-01
TP53-Mutant-vs-TP53-NonMutant
8.047800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
